TREATMENT OF AUTOIMMUNE HEMOLYTIC ANAEMIA WITH RITUXIMAB
<p>Background. Autoimmune haemolytic anaemia (AIHA) is characterised by the presence of autoantibodies directed against autologous erythrocytes. Depending on temperature at which they are active AIHA is classified as AIHA due to warm or cold-reacting antibodies. Glucocorticoids are the mainstay of t...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Slovenian Medical Association
2004-12-01
|
| Seri Bilgileri: | Zdravniški Vestnik |
| Konular: | |
| Online Erişim: | http://vestnik.szd.si/index.php/ZdravVest/article/view/2425 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|